Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacia presents a potent MMP inhibitor at ACS meeting in Chicago

Aug. 28, 2001

Potent, orally bioavailable FTase inhibitors discovered at Aventis

Aug. 28, 2001

CA4P development program continues as planned

Aug. 28, 2001

Sterix patents novel steroid sulfatase inhibitors

Aug. 27, 2001

Schering-Plough highlights next-generation farnesyl protein transferase inhibitors at ACS meeting

Aug. 27, 2001

Study of Cytran's IM-862 in ovarian cancer begins at Magee-Womens Hospital

Aug. 27, 2001

Lilly and Isis establish antisense strategic alliance

Aug. 27, 2001

Novogen to initiate clinical trial of oral phenoxodiol in advanced prostate cancer

Aug. 27, 2001

A new series of MMP inhibitors described by Darwin Discovery

Aug. 24, 2001

Serine protease inhibitors identified by researchers at AxyS

Aug. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.